Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Interleukin-2 × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01370213 2020-05-13

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Phase 2 Completed

25 enrolled 12 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00354172 2017-12-28

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Phase 2 Terminated

16 enrolled 19 charts

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Phase 2 Terminated

12 enrolled 12 charts

LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation